SignatureFD
AXSM icon

SignatureFD’s Axsome Therapeutics AXSM Stock Holding History

SignatureFD’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$126K Buy
681
+435
+177% +$94.6K ﹤0.01% 1428
2026
Q2 		$60.2K Buy
246
+17
+7% +$3.69K ﹤0.01% 1757
2026
Q1 		$38.7K Hold
229
– – ﹤0.01% 1877
2025
Q4 		$41.8K Hold
229
– – ﹤0.01% 1754
2025
Q3 		$27.8K Hold
229
– – ﹤0.01% 1952
2025
Q2 		$23.9K Sell
229
-100
-30% -$10.6K ﹤0.01% 1973
2025
Q1 		$38.4K Hold
329
– – ﹤0.01% 1729
2024
Q4 		$27.8K Hold
329
– – ﹤0.01% 1895
2024
Q3 		$29.6K Buy
329
+16
+5% +$1.4K ﹤0.01% 1854
2024
Q2 		$25.2K Hold
313
– – ﹤0.01% 1846
2024
Q1 		$25K Buy
313
+240
+329% +$20.1K ﹤0.01% 1884
2023
Q4 		$5.81K Sell
73
-64
-47% -$4.28K ﹤0.01% 2456
2023
Q3 		$9.6K Buy
137
+64
+88% +$4.78K ﹤0.01% 2231
2023
Q2 		$5.25K Sell
73
-20
-22% -$1.48K ﹤0.01% 2499
2023
Q1 		$5.74K Sell
93
-634
-87% -$41.7K ﹤0.01% 2455
2022
Q4 		$56.1K Buy
727
+627
+627% +$37.5K ﹤0.01% 1302
2022
Q3 		$4K Hold
100
– – ﹤0.01% 2496
2022
Q2 		$4K Sell
100
-27
-21% -$854 ﹤0.01% 2494
2022
Q1 		$5K Sell
127
-451
-78% -$14K ﹤0.01% 2460
2021
Q4 		$22K Buy
578
+320
+124% +$11.8K ﹤0.01% 1736
2021
Q3 		$9K Buy
258
+166
+180% +$6.47K ﹤0.01% 2101
2021
Q2 		$6K Buy
92
+15
+19% +$900 ﹤0.01% 2184
2021
Q1 		$4K Buy
77
+62
+413% +$4.36K ﹤0.01% 2205
2020
Q4 		$1K Buy
15
+2
+15% +$150 ﹤0.01% 2386
2020
Q3 		$1K Buy
+13
New +$1.01K ﹤0.01% 2366

Other funds holding AXSM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

SignatureFD's AXSM Position: Q3 2026 in Review

SignatureFD increased its Axsome Therapeutics (AXSM) stake by 177% in Q3 2026, buying an estimated $94.6K and bringing the position to 681 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

SignatureFD first reported a position in AXSM in Q3 2020 and has held it in 25 quarters since. 185 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • SignatureFD held 681 shares of Axsome Therapeutics worth $126K as of Q3 2026.
  • SignatureFD bought 435 Axsome Therapeutics shares in Q3 2026, an estimated $94.6K.
  • Axsome Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1428 holding.
  • SignatureFD first reported a position in Axsome Therapeutics in Q3 2020 and has held it in 25 quarters since.
  • 185 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.